Evidence map›Paper›PMID 16237201›Full record

ReviewSchizophrenia bulletin2006

Emerging empirical evidence on the ethics of schizophrenia research.

Laura B Dunn, Philip J Candilis, Laura Weiss Roberts

Abstract readReview
In one paragraph

Review in Schizophrenia bulletin, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Increasing participation of people with thought disorder in clinical research.European psychiatry : the journal of the Association of European Psychiatrists · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The effect of depression on the decision to join a clinical trial.Journal of consulting and clinical psychology · 2017
    Article
  11. Article
  12. Article
  13. Customising informed consent procedures for people with schizophrenia in India.Social psychiatry and psychiatric epidemiology · 2015
    Article
  14. Review
  15. Article
  16. Article
  17. Screening for understanding of research in the inpatient psychiatry setting.Journal of empirical research on human research ethics : JERHRE · 2011
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Laura B DunnDepartment of Psychiatry, University of California, San Diego, USA. Ldunn@ucsd.edu
Philip J Candilis
Laura Weiss Roberts

Funding

ENHANCING INFORMED CONSENT IN LATE-LIFE PSYCHOSISK23MH066062 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DUNN, LAURA B. · 2002 to 2006
$839k
COMPETENCE OF HUMAN SUBJECTS TO CONSENT TO RESEARCHK01MH001851 · NIMH · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CANDILIS, PHILIP J · 1999 to 2003
$457k
PSYCHIATRIC RESEARCH ETHICS: SCIENCE AND SAFEGUARDSK02MH001918 · NIMH · UNIVERSITY OF NEW MEXICO · PI ROBERTS, LAURA W · 1999 to 2002
$425k
NIMH NIH HHS K01 MH001851NIMH NIH HHS K02 MH001918NIMH NIH HHS K23 MH066062NIMH NIH HHS MH01851NIMH NIH HHS MH66062
6 · The paper itself

Abstract

Many challenging ethical questions come with the scientific efforts to understand the nature and treatment of schizophrenia. The empirical study of ethical aspects of schizophrenia research has sought to clarify and resolve many of these questions. In this article we provide an overview of the existing data-based literature on schizophrenia research ethics and outline directions for future inquiry. We examine 5 broad categories of inquiry into the ethics of schizophrenia research: (1) Scientific designs (eg, placebo-controlled studies and medication-free intervals, prodromal and high-risk research, and genetics research); (2) informed consent and decision-making capacity, including assessment of decisional abilities, as well as intervention studies; (3) understanding and perceptions of risk and benefit (including the therapeutic misconception); (4) influences on research participation (including voluntarism, altruism, and other motivations); and (5) key participant safeguards, such as protocol review and participant advocates. We discuss how empirical work in each of these areas answers certain questions and raises new ones. Finally, we highlight important gaps in our understanding of ethically relevant aspects of schizophrenia research and offer a specific research agenda for empirical ethics.

Indexed as

EmpiricismBiomedical ResearchDecision MakingHumansInformed ConsentMental Health ServicesSchizophreniaUnited States

Identifiers

PMID16237201
PMCPMC2632189

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.